Supplemental Materials for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Published: 13 October 2023| Version 2 | DOI: 10.17632/dhtrp945bn.2
Contributors:
Joseph Merola, Lawrence C Parish, Charles Lynde, Lyn Guenther, Jean-Philippe Lacour, Petra Staubach, Sue Cheng, Maria Paris, Hernan Picard, Cynthia Deignan, Shauna Jardon, Mindy Chen, Kim PappDescription
Mendeley Supplemental Figures for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial. J Am Acad Dermatol. 2023.
Files
Categories
Clinical Trial, Safety, Therapeutics, Controlled Clinical Trial, Psoriasis, Quality of Life